Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In one landmark trial that followed more than 17,000 people for more than six years, GLP-1 drugs reduced the risk of heart attack, stroke and cardiovascular death by 20% among adults with overweight or obesity and cardiovascular disease
Month 6: Full protocol benefits realized
Patients seeking weight management support should consult their GP for referral to NHS tiered weight management services, which provide evidence-based, multidisciplinary care
There have been studies showing GLP-1 medications improving cardiovascular health, cognitive health, [and] Recent research has also shown that GLP-1 drugs may be associated with improved breast cancer survival rates and reduced recurrence in people with obesity and related conditions
Furthermore, our dedicated team of healthcare professionals is committed to providing personalized care to each patient
